Cita APA

Chen, L., Siveke, J. T., Bodoky, G., Li, C., Cunningham, D., & Macarulla Mercadé, T. (2019). Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial.

Citación estilo Chicago

Chen, Li-Tzong, Jens T. Siveke, György Bodoky, Chung-Pin Li, David Cunningham, y Teresa Macarulla Mercadé. Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial. 2019.

Cita MLA

Chen, Li-Tzong, et al. Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial. 2019.